Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.
Clinical trial NCT02474082 · COMPLETED
Trial details
- NCT number
- NCT02474082
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-06-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.